Last update 21 Mar 2026

TC011

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Target
CD19
Action
inhibitors
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication
Refractory Follicular LymphomaB-cell lymphoma refractoryDiffuse large B-cell lymphoma refractory+ [3]
Inactive Indication-
Originator Organization
Ticaros Co., Ltd.
Active Organization
Ticaros Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with TC011
NCT07360288
/ Not yet recruitingPhase 2
A Multi-center, Single-arm, Open-label Phase II Study to Evaluate the Efficacy and Safety of TC011 in Patients With Relapsed or Refractory Follicular Lymphoma
NCT07473167
/ RecruitingPhase 1/2
A Multi-center, Single Arm, Open-label Phase 1/2 Clinical Trial to Evaluate Safety, and to Explore Efficacy of TC011(CD19 Targeted CAR-T) in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients
100 Clinical Results associated with TC011
Login to view more data
100 Translational Medicine associated with TC011
Login to view more data
100 Patents (Medical) associated with TC011
Login to view more data
100 Deals associated with TC011
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Refractory Follicular LymphomaPhase 2-
Ticaros Co., Ltd.
01 Mar 2026
B-cell lymphoma refractoryPhase 2
South Korea
Ticaros Co., Ltd.
03 Aug 2023
Diffuse large B-cell lymphoma refractoryPhase 2
South Korea
Ticaros Co., Ltd.
03 Aug 2023
Follicular LymphomaPhase 2
South Korea
Ticaros Co., Ltd.
03 Aug 2023
High grade B-cell lymphomaPhase 2
South Korea
Ticaros Co., Ltd.
03 Aug 2023
Mediastinal large B-cell lymphomaPhase 2
South Korea
Ticaros Co., Ltd.
03 Aug 2023
LymphomaPreclinical-
Ticaros Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free